Zhejiang Expressway Co Ltd (0576)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 20 Oct 2026
Key indicators
| Last close | HKD 6.035 |
|---|---|
| 52-week range | 5.695 – 7.659 |
| Return, 1 month / 3 months | +0.1% / −8.4% |
| Return, 1 year / 3 years | −11.3% / +36.0% |
| Trend | Below its 200-day average |
| RSI (14) | 51 |
| Volatility (1 year) | 23.4% |
| Worst drawdown (1 year) | -24.7% |
| Average daily value traded | 56.42M HKD |
| Dividend yield | 7.4% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Zhejiang Expressway Company operates toll expressways and highways in Zhejiang Province in eastern China, collecting tolls from drivers and freight operators who use its road network. The company also provides related services along its routes and has interests in securities and financial services businesses. It is based in Hangzhou and serves motorists, transport companies and other road users across its home region.
The shares are listed on the Hong Kong Stock Exchange in Hong Kong under the code 0576, and the price on this page is in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Zhejiang Expressway Co Ltd (0576) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 6.035 on 20 October 2026.
Its price-based Market X-Ray is 70 out of 100 (a strong price profile), ranking 388 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 11.3% and over the last three months it fell 8.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 62 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -7.7% | ||
| From 52-week high | -20.7% | ||
| Momentum | 49 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -8.4% | ||
| 6-month return | -15.2% | ||
| 12-month return, skipping the last month | -11.4% | ||
| Stability (higher is calmer) | 90 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.4% | ||
| Worst drawdown, 1 year (smaller is calmer) | -24.7% | ||
| Liquidity | 88 · Strong | Trades actively. | |
| Average daily value traded | 56.42M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 68 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 7.4% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | −0.5% |
|---|---|
| 1 month | +0.1% |
| 3 months | −8.4% |
| 6 months | −15.2% |
| 1 year | −11.3% |
| 3 years | +36.0% |
| 5 years | – |
Signals
| 50-day / 200-day average | 6.119 / 6.541 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.112 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 8 May 2026 | HKD 0.4476 |
| 29 Apr 2025 | HKD 0.4171 |
| 10 May 2024 | HKD 0.3524 |
| 8 May 2023 | HKD 0.4261 |
| 5 Jul 2022 | HKD 0.4394 |
| 23 Apr 2021 | HKD 0.4227 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.